Journal of Histochemistry and Cytochemistry, Vol. 51, 1331-1341, October 2003, Copyright © 2003, The Histochemical Society, Inc.


ARTICLE

Perlecan, the Multidomain Heparan Sulfate Proteoglycan of Basement Membranes, Is also a Prominent Component of the Cartilaginous Primordia in the Developing Human Fetal Spine

James Melrosea, Susan Smitha, Peter Ghosha, and John Whitelockb
a The Institute of Bone and Joint Research, The University of Sydney, at the Royal North Shore Hospital of Sydney, St. Leonards, Australia
b Biomics Research Services, Homebush, Australia

Correspondence to: James Melrose, Raymond Purves Bone and Joint Research Laboratories, Inst. of Bone and Joint Research, Level 5, The University Clinic, Building B26, The Royal North Shore Hospital, St. Leonards NSW 2065, Australia. E-mail: jmelrose@mail.usyd.edu.au


  Summary
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

The aim of this study was to localize perlecan in human fetal spine tissues. Human fetal spines (12–20 weeks; n=6) were fixed in either Histochoice or 10% neutral buffered formalin, routinely processed, paraffin-embedded, and 4-µm sagittal sections were cut and stained with toluidine blue, H&E, and von Kossa. Perlecan, types I, II, IV, and X collagen, CD-31, aggrecan core protein, and native and {Delta}-HS 4, 5 hexuronate stub epitopes were immunolocalized. Toluidine blue staining visualized the cartilaginous vertebral body (VB) rudiments and annular lamellae encompassing the nucleus pulposus (NP). Von Kossa staining identified the VB primary center of ossification. Immunolocalization of type IV collagen, CD-31, and perlecan delineated small blood vessels in the outer annulus fibrosus (AF) and large canals deep within the VBs. Perlecan and type X collagen were also prominently expressed by the hypertrophic vertebral growth plate chondrocytes. Aggrecan was extracellularly distributed in the intervertebral disk (IVD) with intense staining in the posterior AF. Notochordal tissue stained strongly for aggrecan but negatively for perlecan and types I and II collagen. Type I collagen was prominent in the outer AF and less abundant in the NP, while type II collagen was localized throughout the IVD and VB. The immunolocalization patterns observed indicated key roles for perlecan in vasculogenic, chondrogenic, and endochondral ossification processes associated with spinal development.

(J Histochem Cytochem 51:1331–1341, 2003)

Key Words: perlecan, HS proteoglycan, human fetal cartilage, development, vertebral growth plate, hypertrophic growth plate, chondrocytes


  Introduction
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

PERLECAN is a member of a group of heparan sulfate (HS)/chondroitin sulfate (CS)-substituted proteoglycans of basement membranes that are implicated in cell growth and differentiation (Aviezer 1994 ; Iozzo et al. 1994 ). Perlecan is one of the most abundant extracellular matrix (ECM) proteoglycans during early stages of skeletogenesis and is first detectable at the two-cell blastocyst stage of embryonic development (Carson et al. 1993 ; Handler et al. 1997 ; Costell et al. 1999 ; French et al. 1999 ; Chang et al. 2000 ; Nugent et al. 2000 ; Clayton et al. 2001 ; Iozzo 2001 ; Iozzo and San Antonio 2001 ; Kunjathoor et al. 2002 ). Crucial roles have been established for perlecan in cartilage development and in endochondral ossification (Handler et al. 1997 ; Arikawa-Hirasawa et al. 1999 , Arikawa-Hirasawa et al. 2001a , Arikawa-Hirasawa et al. 2001b , Arikawa-Hirasawa et al. 2002 ; Costell et al. 1999 ; French et al. 1999 ). The very high mortality rates of embryos and the severe skeletal and growth plate abnormalities evident in perlecan gene knockout mice testify to the critical role of perlecan in skeletal development (French et al. 1999 ). Mutations in the HSPG-2 perlecan gene lead to severe chondrodysplasia, dyssegmental spinal ossification, defective cephalic development, and abnormal organization of the growth plate cartilage, leading to severe disruptions in the endochondral ossification process (Arikawa-Hirasawa et al. 1999 , Arikawa-Hirasawa et al. 2001a , Arikawa-Hirasawa et al. 2001b , Arikawa-Hirasawa et al. 2002 ; Nicole et al. 2000 ). The first human perlecan gene mutation has been identified in Schwartz–Jampel syndrome, chondrodystrophic myotonia (Arikawa-Hirasawa et al. 1999 , Arikawa-Hirasawa et al. 2001a , Arikawa-Hirasawa et al. 2001b , Arikawa-Hirasawa et al. 2002 ; Nicole et al. 2000 ).

The human perlecan gene encodes a large core protein of 467 kD, which consists of five discrete domains (I–V) with homology to the laminin A-chain, low-density lipoprotein receptor, neural cell adhesion molecule, and epidermal growth factor (Noonan et al. 1991 ; Murdoch et al. 1992 , Murdoch et al. 1994 ). Domain I is the main acceptor for glycosaminoglycan (GAG) substitution in human perlecan and contains a cluster of three potential attachment sites. Domain V has also been shown to be a potential GAG acceptor region in mouse perlecan (Friedrich et al. 1999 ; Tapanadechopone et al. 1999 ). Perlecan interacts with a range of basement membrane and ECM components including nidogen/entactin, type IV collagen, fibronectin, fibulin-2, laminin, PRELP, type XIII collagen, and heparin (Friedrich et al. 1999 ; Hopf et al. 2001 ; Iozzo and San Antonio 2001 ; Bengtsson et al. 2002 ; Tu et al. 2002 ). Heparan sulfate substitution in domain I of perlecan promotes binding to laminin I, fibronectin, and type IV collagen. This is important not only in developmental processes involving cellular attachment but also in the structural organization of the developing cartilaginous extracellular matrix (Iozzo et al. 1994 ; Friedrich et al. 1999 ; Tapanadechopone et al. 1999 ; Hopf et al. 2001 ; Iozzo and San Antonio 2001 ). The HS side chains of perlecan can also bind and store growth factors such as fibroblast growth factor (FGF)-1, -2, -4, and -9 and can act as low-affinity co-receptors, underscoring its importance in growth and development (Handler et al. 1997 ; Arikawa-Hirasawa et al. 1999 ; Costell et al. 1999 ; French et al. 1999 ; Klint and Claesson-Welsh 1999 ; Chang et al. 2000 ; Clayton et al. 2001 ; Iozzo 2001 , Iozzo and San Antonio 2001 ; Knox et al. 2001 , Knox et al. 2002 ). FGF-7 has also been shown to bind avidly to domain III of the perlecan core protein, and this appears to regulate the activity of this growth factor (Mongiat et al. 2000 ).

Perlecan has previously been demonstrated in a range of embryonic and newborn mouse and rat tissues including the spine and intervertebral disc (Handler et al. 1997 ; Arikawa-Hirasawa et al. 1999 , Arikawa-Hirasawa et al. 2001a , Arikawa-Hirasawa et al. 2001b , Arikawa-Hirasawa et al. 2002 ; Costell et al. 1999 ; French et al. 1999 ; Hayes et al. 2001 ). Perlecan has been immunolocalized in basement membrane-rich human tissues such as liver and kidney (Murdoch et al. 1994 ), in the intima of balloon catheter-injured porcine carotid arteries (Nugent et al. 2000 ), and in intimal atherosclerotic lesions in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice (Kunjathoor et al. 2002 ), in the infarct zone in a mouse myocardial infarction model (Nakahama et al. 2000 ), and in the follicular basal lamina of bovine reproductive tissues (McArthur et al. 2000 ).

Perlecan was first localized in cartilage and chondrosarcoma by Iozzo et al. 1994 and was later demonstrated as an important matrix component of bovine nasal cartilage (SundarRaj et al. 1995 ). Handler et al. 1997 subsequently demonstrated perlecan in murine disk and Hayes et al. 2001 in rat disk tissues. More recently, Melrose et al. 2002 localized perlecan in the vertebral growth plate and cartilaginous end plates of the ovine intervertebral disk. Surprisingly, despite its obvious importance to developmental processes, perlecan has yet to be immunolocalized in human spinal tissues. The present study was therefore initiated to immunolocalize perlecan in human fetal spinal tissues using a recently characterized monoclonal antibody to perlecan domain I, MAb A76 (Whitelock et al. 1996 , Whitelock et al. 1999 ; Melrose et al. 2002 ). The perlecan localizations were compared and contrasted with the distribution of other matrix components including types I, II, IV, and X collagen, as well as aggrecan, to assess the role of perlecan in the structural organization of the rapidly developing cartilaginous primordia of the human fetal spinal column.


  Materials and Methods
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

All materials and suppliers were as noted previously (Melrose et al. 2002 ). Details of the antibodies used are provided in Table 1. Histochoice fixative was obtained from Amresco (Solon, OH). MAbs 10-E-4, 3-G-10 (David et al. 1992 ), and heparitinase were obtained from Seikegaku (Tokyo, Japan). Anti-aggrecan G1 domain (MAb AD11-2A9) was from Bioscience Europe (Nivelles, Belgium). Anti-collagen type I (clone I8H5) and type II (clone II-4CII) antibodies were purchased from ICN (N. Ryde, NSW, Australia); anti type-IV collagen antibody (clone CIV-22), and anti CD-31 (PECAM, platelet endothelial cell adhesion molecule, clone JC/70A) were purchased from DAKO Australia (Botany, NSW, Australia). The anti-type X collagen and perlecan domain 1 antibodies have been described elsewhere (Gibson et al. 1996 ; Whitelock et al. 1996 , Whitelock et al. 1999 ; Melrose et al. 2002 ).


 
View this table:
[in this window]
[in a new window]
 
Table 1. Details of the monoclonal antibodies, fixatives, and epitope retrieval procedures used in this study

Preparation of Human Fetal Tissues for Histology and Histological Procedures
Six 12–20-week-old human fetuses were obtained at termination of pregnancy after ethical approval by The Human Care and Ethics Review Board of The Royal North Shore Hospital. The posterior elements were dissected from the fetal spines and they were longitudinally bisected in a mid-vertical plane. Half of the spines were fixed in Histochoice for 24 hr and the remaining specimens were fixed in 10% (v/v) neutral buffered formalin for 24 hr. Selected specimens were also briefly decalcified in 10% formic acid for up to 24 hr. The tissues were dehydrated in graded alcohols, embedded in Paraplast, and 4-µm sections were cut and mounted on StarfrostPlus glass microscope slides (Menzel-Glaser; Heidelburg, Germany). The tissue sections were then de-paraffinized in xylene before rehydration through graded ethanol washes to water.

Histochemistry
Neutral formalin-fixed tissue sections were routinely stained for 10 min with 0.04% (w/v) toluidine blue in 0.1 M sodium acetate buffer, pH 4.0, to visualize the tissue proteoglycans. This was followed by 2-min counterstaining in an aqueous 0.1% (w/v) fast green FCF stain which aids in the differentiation of the areas stained for proteoglycan. Hematoxylin and eosin-stained tissue sections were used to examine cell morphology. Mineral deposition in the vertebral center of ossification was visualized in non-decalcified mid-sagittal sections of human fetal spinal tissues using a further modification developed in house at the Department of Anatomical Pathology, Royal North Shore Hospital (NSW, Australia) of the modification of the von Kossa procedure (von Kossa 1901 ) described by Drury and Wallington 1967 . Tissue sections were briefly stained with silver nitrate (1.5% w/v) in the dark for 90 sec to 2 min. The sections were then incubated with hydroquinone (1% w/v) for 1–2 min and finally with sodium thiosulfate (5% w/v) for 5 min. The sections were then counterstained with H&E and mounted in Eukitt.

Immunohistochemistry
The immunolocalizations were undertaken using a Sequenza vertical cover-plate immunostaining system (Immunon) as described earlier (Melrose et al. 2002 ). Details of the antibodies used in this study and of the epitope retrieval steps required by specific antibodies and fixation conditions are provided in Table 1. Endogenous peroxidase activity was initially blocked by incubating the tissue sections with 3% H2O2 for 5 min. For the perlecan and aggrecan immunolocalizations, Histochoice-fixed specimens were used. The tissue sections were pre-digested with bovine testicular hyaluronidase 500 U/ml for 1 hr at 37C in phosphate buffer, pH 5.0, followed by three washes in 50 mM Tris-HCl buffer, pH 7.6, containing 0.15 M NaCl and 0.05% Tween-20 (TBS-T). For MAb 3-G-10, a 2-hr digestion with heparitinase (2.5 mU/ml) in 50 mM HEPES buffer, pH 7.0, containing 100 mM NaCl, 3 mM CaCl2, and 1 mg/ml bovine serum albumin was used to generate the {Delta}-4,5 uronate HS stub epitopes identified by this antibody. MAb 10-E-4, in contrast, identifies native HS chains, and heparitinase digestion destroys 10-E-4 reactivity (David et al. 1992 ). Some of the antibodies used on formalin-fixed tissue in this study also required enzymatic pre-digestion steps to effect epitope retrieval (see Table 1 for details). This included proteinase K digestion for 6 min at room temperature (RT) using a proprietary proteinase K reagent (DAKO cat # S03020) according to the manufacturer's instructions. This was followed in some cases by a hyaluronidase digestion step using the conditions outlined above but employing a hyaluronidase concentration of 1000 U/ml (see Table 1 for details). Histochoice- and neutral formalin-fixed tissue specimens were both suitable for the immunolocalization of types I, II, IV, and X collagen, native HS, {Delta}-HS stub epitope, and CD-31. After the pre-digestion procedures the sections were rinsed twice in TBS-T and blocked with 10% swine serum for 10 min at RT before addition of primary antibody. Incubation with primary antibodies was performed overnight at 4C using the dilutions specified in Table 1. Appropriate biotinylated secondary antibodies and horseradish peroxidase-conjugated streptavidin were used for visualization with Nova Red substrate for color development. Control sections were also prepared in which an irrelevant isotype-matched primary antibody was substituted for the primary antibody of interest. Commercial (DAKO) isotype-matched mouse IgG (DAKO code X931) or IgM (DAKO code X942) control antibodies (as appropriate) were used for this step. The DAKO products X931 and X942 are mouse monoclonal IgG1 (clone DAK-GO1) and monoclonal IgM (clone DAK-GO8) antibodies directed against Aspergillus niger glucose oxidase, an enzyme that is neither present nor inducible in mammalian tissues. In the case of the 3-G-10 antibody, the heparitinase digestion step was omitted in the control sample, and for the 10-E-4 antibody the control sample was treated with heparitinase.


  Results
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Immunolocalization of aggrecan, perlecan, and types I and II collagen in longitudinal mid-sagittal sections of human fetal spinal tissues showed some interesting differences in the spatial distributions of these matrix components (Fig 1A–1H). Toluidine blue and von Kossa staining clearly showed the cartilaginous nature of the primordial vertebral bodies and the extent of mineralization in the ossifying center at the 12–20-week stage of spinal development (Fig 1A and Fig 2C). Type I collagen was confined mainly to the intervertebral disk, with diminished staining evident in the NP (Fig 1B). Strong staining of the anterior and posterior longitudinal ligaments was also observed but no staining of the cartilaginous vertebral body rudiment (Fig 1B). This contrasted with type II collagen, which was more extensively distributed throughout the cartilaginous vertebral body rudiment and intervertebral disk (Fig 1C). However, the outer AF, together with the anterior and posterior longitudinal ligaments, showed no significant staining for type II collagen (Fig 1C). Aggrecan was detected primarily in the intervertebral disk and very little staining was evident for this proteoglycan in the cartilaginous vertebral rudiment (Fig 1D). Staining for aggrecan was generally stronger in the posterior AF. Some cell-associated aggrecan staining in the hypertrophic vertebral growth plate chondrocytes was also evident (Fig 1D). Further examination of the outer AF confirmed the spatial localization patterns for the aforementioned matrix components (Fig 1E–1H). Heparan sulfate was diffusely localized throughout the outer AF and displayed somewhat higher levels evident at the cranial and caudal margins of the AF, where it merged with the vertebral growth plates. The extreme periphery of the outer AF lamellae stained negatively for type I collagen (Fig 1F). However, the outer AF stained positively for type I collagen. Type II collagen staining, in contrast, was negative throughout the outer AF except at its margins, where it merged with the vertebral growth plate. Type II collagen staining intensity increased steadily in moving through the inner AF towards the NP (Fig 1G). Aggrecan was again strongly localized in the outer AF tissues examined (Fig 1G).



View larger version (79K):
[in this window]
[in a new window]
 
Figure 1. Immunohistochemical and histochemical localization of ECM components in longitudinal mid-sagittal sections of a 14-week-old human fetal spine. (A) Anionic proteoglycan stained with toluidine blue. (B) Immunolocalization of type I collagen. (C) Type II collagen. (D) Aggrecan. Higher-power views of the outer annulus fibrosus are also depicted in (E–H). Immunolocalization of {Delta}-4, 5 unsaturated HS stub epitope (E), type I collagen (F), type II collagen (G), and aggrecan (H). The cranial, caudal, posterior, and anterior aspects of sections A–D are indicated in A, as are the locations of the outer annulus fibrosus (*) inner annulus fibrosus (**), nucleus pulposus (np) of the intervertebral disc (IVD), and the posterior longitudinal ligaments (PLL) and the vertebral bodies. Bars = 100 µm.



View larger version (121K):
[in this window]
[in a new window]
 
Figure 2. Immunolocalization and histochemical localization of intervertebral disk and vertebral components in 12–14-week-old human fetal spinal specimens. (A) Elevated perlecan expression in the hypertrophic chondrocytes of the vertebral growth plate (*, arrows) adjacent to the vertebral ossification center (OC). Bar = 1 mm, vertical mid-sagittal section. (B) Type X collagen localization in terminally differentiated hypertrophic vertebral growth plate chondrocytes located adjacent to the ossification center. Bar = 0.5 mm. (C) Von Kossa staining of calcific deposits in a primary vertebral ossification center. Bar = 0.5 mm. (D) Higher-power views of a segment of vertebral growth plate depicted in the boxed area in A, demonstrating the localization of cell-associated {Delta}-4, 5 unsaturated HS stub epitope (D) and perlecan (E). Bars = 100 µm. (F) Immunolocalization of cell-associated perlecan in a parasagittal section of 12-week lumbar (L4–L5) intervertebral disk. Bar = 200 µm.

Perlecan was produced abundantly by the hypertrophic chondrocytes of the vertebral growth plate (Fig 2A). The most terminally differentiated hypertrophic chondrocytes of the vertebral growth plate located adjacent to the vertebral center of ossification also strongly expressed type X collagen, confirming their differential state (Fig 2B). On closer inspection of the vertebral growth plate, a pericellular localization of HS and perlecan around small columns of hypertrophic vertebral growth plate chondrocytes was apparent, although their distributions were not identical (Fig 2D and Fig 2E). Perlecan was also localized diffusely throughout the cartilaginous vertebral body rudiment and was associated pericellularly with intervertebral disk cells in the NP and in the inner and outer AF (Fig 1F). Perlecan displayed a similar distribution to that previously documented for type IIA collagen in developing intervertebral disk tissues (Zhu et al. 2001 ).

Type IV collagen was also extracellularly localized to the outer AF and to many of the basal laminae of blood vessels in the outermost annular lamellae (Fig 3A and Fig 3C). The CD31, perlecan, and {Delta}-HS MAbs used in the present study also were localized to the blood vessels in the outer AF (Fig 3B, Fig 3D and Fig 3E). Small arterioles and venules were also discernable in many cases in the outer AF of these developing spinal tissues (Fig 3A–3E).



View larger version (123K):
[in this window]
[in a new window]
 
Figure 3. Immunolocalization of basal lamina components and endothelial cells associated with blood vessels in the outer AF (arrows) of an L4–L5 intervertebral disk from a 14-week human fetal spine. (A,C) Type IV collagen. (B) CD-31. (D) Perlecan. (E) {Delta}-4, 5 unsaturated stub HS epitope. Small arterioles (single asterisk) and adjacent venules (double asterisk) are visible and the widespread distribution of vessels in the outer collagenous lamellae of the developing AF. Bars: A = 100 µm; B–E = 50 µm.

Cartilage canals in the cartilaginous vertebral body rudiments were also prominently featured in longitudinal parasagittal sections of the human fetal spines examined. Several basal lamina components were also immunolocalized to the lining tissues of these cartilage canals, including native and {Delta}-HS hexuronate stub epitope (Fig 4A and Fig 4C), perlecan (Fig 4E), and type IV collagen (Fig 4F). Higher-power assessment of individual cartilage canals demonstrated the presence of endothelium-like cells on the basal lamina of the canal. These cells also stained positively with the MAb to CD-31 (Fig 4D). Occasional clumps of red blood cells were also observed entrapped within these cartilage canals, suggesting that these structures may have some important nutritional role in these rapidly developing cartilaginous primordial spinal tissues.



View larger version (89K):
[in this window]
[in a new window]
 
Figure 4. Composite figure depicting the presence of cartilage canals in the cartilaginous vertebral body rudiments in vertical parasagittal longitudinal sections of a 12-week-old human fetal spine. (A) Higher-power view of an individual cartilage canal depicting the immunolocalization of native HS lining the canal (A), and negative control (B). MAb 3-G-10 was used in B without a heparitinase pre-digestion step. {Delta}-4, 5 unsaturated HS stub epitope detected by MAb 3-G-10 following heparitinase digestion (C). Very precise staining of endothelial cells (CD-31) lining a canal. (D) Strong staining for perlecan lining a vertebral cartilage canal which is almost completely filled with other matrix material (E). An adjacent canal also contained moderate staining for type IV collagen (F). Bars = 100 µm.

Figure 5. Immunolocalization of perlecan (A–C), type II collagen (D), type I collagen (E), and aggrecan (F) in the notochord (N) and adjacent NP (np)/inner AF (iaf) of lumbar intervertebral disks from 12 (A–C) and 14 (D–F)-week-old fetal human spines. The notochord stained negatively for perlecan (A–C) and types I and II collagen (E,D) but positively for aggrecan (F). The notochordal sheath (ns, arrow) stained positively for perlecan (C). Bars = 100 µm.

Further immunolocalization of perlecan, types I and II collagen, and aggrecan in parasagittal sections of additional 12–14-week-old human fetal spinal tissues confirmed that perlecan was a prominent component of the NP and inner AF. However, perlecan was not present in the notochordal tissue, but some staining of the notochordal sheath for perlecan was noted (Fig 5A–5C). Type II collagen was also localized to both the inner AF and NP but, like type I collagen, it was not identified in the notochordal tissue (Fig 5D and Fig 5E). Interestingly, this same tissue stained strongly with the anti-aggrecan antibody (Fig 5 F).


  Discussion
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

The formation of the primordial spinal cartilages that will act as developmental scaffolds and eventually become the ossified vertebral bodies is a complex process. Initially, this involves the migration of precursor cells from remote places to form mesenchymal cell aggregates. Sclerotome cells located lateral to the neural tube also migrate ventrally towards the notochord. This eventually leads to the formation of the primordial cartilage around the notochord, which will become the vertebral body (Gotz et al. 1995 ; Christ et al. 2000 ; Fleming et al. 2001 ). This cell-migration process is guided by morphogens such as Sonic Hedgehog protein secreted by the notochord and by Pax-1, Pax-9, and Hox gene expression (Smith and Tuan 1994 ; Burke et al. 1995 ; Peters et al. 1999 ). Growth differentiation factor-11 (Gdf-11), also known as bone morphogenetic protein (BMP)-11 also determines the anterior–posterior patterning of the axial skeleton (McPherron et al. 1999 ). This is a complex process involving the interplay of core-binding transcription factor alpha-1 (Cbfa-1), other local BMPs and their receptors (Monsoro-Burq et al. 1996 ; Ducy and Karsenty 2000 ; Yamaguchi et al. 2000 ), and cartilage-derived morphogenetic proteins (Tsumaki et al. 1999 ). Sonic and Indian Hedgehog are also important bone-inductive factors that critically direct the assembly of the axial skeleton (Iwasaki et al. 1997 ; Nakamura et al. 1997 ; Yuasa et al. 2002 ). Perlecan is detectable as early as the two-cell blastocyst stage of embryonic development (Carson et al. 1993 ; Smith et al. 1997 ) and can bind FGF-1, -2, -4, -7, and -9 (Aviezer 1994 ; Klint and Claesson-Welsh 1999 ; Chang et al. 2000 ; Mongiat et al. 2000 ; Clayton et al. 2001 ; Knox et al. 2001 , Knox et al. 2002 ). The ability of perlecan to act as a low-affinity co-receptor for the FGFs and its involvement in subsequent cell signaling events indicate that it has a fundamental role in cell proliferation and differentiation events critical to early spinal development. HS proteoglycans have also recently been demonstrated to sequester noggin in the ECM of costal cartilage (Paine-Saunders et al. 2002 ). Therefore, perlecan may also have the potential to regulate the bioavailability of BMPs that regulate the development of the rudimentary cartilage of the spinal column. The widespread distribution of perlecan in the cartilaginous vertebral body rudiments observed in the present study supports the proposal that perlecan has an important regulatory role in these early developmental processes in the spine.

Handler et al. 1997 and Hayes et al. 2001 also examined perlecan expression in embryonic to newborn mouse and in rat spinal tissues and demonstrated its widespread distribution in the cartilaginous spinal primordia, suggesting potential roles for perlecan in chondrogenesis, endochondral ossification, and vasculogenic processes related to spinal development. The present study has extended these earlier observations in human tissues and has also compared the distribution of perlecan with other well-characterized ECM components such as types I, II, IV, and X collagen and aggrecan. It was somewhat surprising that aggrecan, the major proteoglycan of weight-bearing connective tissues (Knudson and Knudson 2001 ) and considered to be a primary chondrogenic phenotypic marker, was not as extensively distributed in the cartilaginous vertebral rudimentary spinal tissues as was perlecan. However, perlecan did display a similar pericellular distribution pattern in the present investigation to that previously documented for type IIA collagen in the developing intervertebral disk (Zhu et al. 2001 ). This may indicate that perlecan also has an important role in processes relating to spinal primordial cartilage remodeling, vertebral bone formation, and spinal development.

An earlier study from our laboratory also examined the distribution of perlecan and other major ECM components (types I, II, VI, and X collagen, aggrecan) in the newborn ovine intervertebral disk (Melrose et al. 2002 ). Perlecan was also strongly associated pericellularly with hypertrophic growth plate chondrocytes in the cartilaginous end plate and the vertebral growth plates of the newborn ovine disk (Melrose et al. 2002 ), which is consistent with its proposed role in the present investigation in spinal development. However, vascular channels and small blood vessels were less evident in the newborn ovine disk. Therefore, direct comparisons with the present study are not possible. Moreover, it should also be noted that the vertebral growth plate in the ovine spine (as in other quadrupeds) is dissimilar to its counterpart in humans. The newborn ovine vertebral growth plate is particularly well defined and is separated from the cartilaginous endplate (which demarcates the intervertebral disk proper) by a bony vertebral epiphysis. In humans the vertebral growth plate is contiguous with the cartilaginous endplates of the intervertebral disk. Furthermore, in humans the vertebral body is not a "short" long bone. It has a primary ossification center. The centrum and its polar endplates, the vertebral growth plates, act as modified growth zones in a similar manner to the polar growth plate cartilages in a carpal or tarsal bone. However, in contrast to a long-bone physis, the cartilage columns in the human vertebral growth plate in man are short and irregularly arranged. Despite these organizational differences between the newborn ovine and fetal spinal cartilages, the immunolocalization of perlecan to the hypertrophic vertebral growth plate chondrocytes in both studies is consistent with an important role for perlecan in cartilage development, terminal differentiation of growth plate chondrocytes, vertebral bone formation, and spinal development.

The vascularization of the human spine has been the subject of anatomic and microanatomic studies for almost a century, and most attention has focused on the external segmental blood supply and drainage of the vertebral bodies (Skawina et al. 1997 , and references cited therein). Only a few articles have described the intraosseous arteries of the vertebral bodies in detail. Among the more recent studies, a comprehensive description of the extra- and intraosseous vessels of the vertebral bodies was presented by Crock and Yoshizawa 1976 and Ratcliffe 1982 . Skawina et al. 1997 studied the vasculature of the human fetal (17–24-week) vertebral bodies using an acrylic dye injection technique, light microscopy, and corrosion casting methods that were evaluated by scanning electron microscopy. This permitted complete visualization of the vascular system and three-dimensional images of the vertebral microvascular architecture. Three vascularization zones were identified: (a) a peripheral zone containing perichondrial vessels, (b) an intermediate zone of radial vessels, and (c) a central zone of vessels in the ossification center. This is consistent with observations made in the present study. However, the same authors noted a complete absence of blood vessels in the intervertebral spaces, which is surprising considering the findings of the present study. Rudert and Tillmann 1993 , however, used histological and immunohistological methods to demonstrate blood and lymph vessels in the adult human IVD. Therefore, their apparent absence in the Skawina et al. 1997 study may stem from technical limitations evident in the respective methodologies employed.

Skawina et al. 1997 also observed capillary cuffs, which they termed manchettes, surrounding pairs of larger vessels, and considered these as typical vascular arrangements in the developing vertebral cartilage canals. Such vascular arrangements were also observed in the present study (Fig 4). Widened and irregular segments of metaphyseal vessels directed towards the cartilaginous endplates from the ossification center of the intervertebral disk were also observed, which are also consistent with the arrangement of cartilage canals observed in the present study. Cartilage canals have also been observed in human fetal and rabbit vertebral bodies, where they are an important source of nutrition to the avascular disk regions during fetal development (Whalen et al. 1985 ). Such cartilage canals were also observed in spine specimens aged 12–20 weeks in the present investigation. This is therefore in agreement with observations made by Skawina et al. 1997 , who noted that the metaphyseal vessels had started to penetrate the vertebral body cartilages by the second trimester but became incorporated into the ossification center only at 36 weeks of fetal life.

The present study has demonstrated perlecan as a prominent basal lamina component of small peripheral blood vessels in the outer AF and of cartilage canals within the vertebral body rudiment. Basal lamina components have also been immunolocalized to developing epiphyseal cartilage canals (Kai et al. 1992 ) and are considered to have important roles in the vascularization of developing limb bud cartilages (Rayan et al. 2000 ). Furthermore, not only do such vessels have important roles in the nutrition of the rapidly developing cartilaginous spinal tissues but they also have roles in the establishment of the primary centers of ossification in the vertebral bodies. The present study has therefore demonstrated potentially important regulatory roles for perlecan, not only in the initiation but also in the promotion and maintenance of chondrogenesis and osteogenesis, as well as early vasculogenic events, which are critical for normal spinal development.


  Acknowledgments

Supported in part by the National Health and Medical Research Council of Australia (project grant 211266) and by a Seeding Grant from The Lincoln Centre for Research into Bone and Joint Disorders (Royal North Shore Private Hospital; St Leonards, NSW, Australia).

Dr G. Gibson (Henry Ford Hospital, Detroit, MI) is thanked for his kind gift of antibodies to type X collagen.

Received for publication November 25, 2002; accepted April 17, 2003.


  Literature Cited
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Arikawa–Hirasawa E, Le AH, Nishino I, Nonaka I, Ho NC, Francomano CA, Govindraj P et al. (2002) Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome with myotonic myopathy and chondroplasia. Am J Hum Genet 70:1368-1375[Medline]

Arikawa–Hirasawa E, Watanabe H, Takami H, Hassell JR, Yamada Y (1999) Perlecan is essential for cartilage and cephalic development. Nature Gene 23:354-358

Arikawa–Hirasawa E, Wilcox WR, Le AH, Silverman N, Govindraj P, Hassell JR, Yamada Y (2001a) Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutation of the perlecan gene. Nature Gene 27:431-434

Arikawa–Hirasawa E, Wilcox WR, Yamada Y (2001b) Dyssegmental dysplasia, Silverman-Handmaker type: unexpected role of perlecan in cartilage development. Am J Med Genet (Semin Med Genet) 106:254-257[Medline]

Aviezer D (1994) Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis and angiogenesis. Cell 79:1005-1013[Medline]

Bengtsson E, Morgelin M, Sasaki T, Timpl R, Heinegard D (2002) The leucine rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor. J Biol Chem 277:15061-15068[Abstract/Free Full Text]

Burgeson RE, Hollister DW (1979) Collagen heterogeneity in human cartilage: identification of several new collagen chains. Biochem Biophys Res Commun 87:1124-1131[Medline]

Burke AC, Nelson CE, Morgan BA, Tabin C (1995) Hox genes and the evolution of vertebrate axial morphology. Development 121:333-346[Abstract/Free Full Text]

Carson DD, Tang J-P, Julian J (1993) Heparan sulphate proteoglycan (perlecan) expression by mouse embryos during acquisition of attachment competence. Dev Biol 155:97-106[Medline]

Chang Z, Meyer K, Rapraeger AC, Friedl A (2000) Differential ability of HS proteoglycans to assemble the fibroblast growth factor receptor complex in situ. FASEB J 14:137-144[Abstract/Free Full Text]

Christ B, Huang R, Wilting J (2000) The development of the avian vertebral column. Anat Embryol 202:179-194[Medline]

Clayton A, Thomas J, Thomas GJ, Davies M, Steadman R (2001) Cell surface HS proteoglycans control the response of renal interstitial fibroblasts to FGF-2. Kidney Int 59:2084-2094[Medline]

Costell M, Gustafsson E, Aszodi A, Morgelin M, Bloch W, Hunziker E, Addicks K et al. (1999) Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol 147:1109-1122[Abstract/Free Full Text]

Crock HV, Yoshizawa H (1976) The blood supply of the lumbar vertebral column. Clin Orthop 115:6-21[Medline]

David G, Bai XM, Van Der Scheuren B, Cassiman J-P, Van Den Berghe H (1992) Developmental changes in heparan sulphate expression: in situ detection with mAbs. J Cell Biol 119:961-975[Abstract]

Drury RAB, Wallington EA (1967) Carleton's Histological Technique. 4th ed Oxford, Oxford University Press

Ducy P, Karsenty G (2000) The family of bone morphogenetic proteins. Kidney Int 57:2207-2214[Medline]

Fleming A, Keynes RJ, Tannahill D (2001) The role of the notochord in vertebral column formation. J Anat 199:177-180[Medline]

French MM, Smith SE, Akanbi K, Sanford T, Hecht J, Farach–Carson MC, Carson DD (1999) Expression of HS proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in-vitro. J Cell Biol 145:1103-1115[Abstract/Free Full Text]

Friedrich MVK, Gohring W, Morgelin M, Brancaccio A, David G, Timpl R (1999) Structural basis of GAG modification and of heterotypic interactions of perlecan domain V. J Mol Biol 294:259-270[Medline]

Gibson G, Francki K, Caterson B, Foster B (1996) Type X collagen is colocalized with a proteoglycan epitope to form distinct morphological structures in bovine growth cartilage. Bone 19:307-315[Medline]

Götz W, Osmers R, Herken R (1995) Localisation of extracellular matrix components in the embryonic human notochord and axial mesenchyme. J Anat 186:111-121[Medline]

Gysen P, Franchimont PJ (1984) Radioimmunoassay of proteoglycans. J Immunoassay 5:221-243[Medline]

Handler M, Yurchenko PD, Iozzo RV (1997) developmental expression of perlecan during murine embryogenesis. Dev Dyn 210:130-145[Medline]

Hayes AJ, Benjamin M, Ralphs JR (2001) Extracellular matrix in the development of the intervertebral disc. Matrix Biol 20:107-121[Medline]

Hopf M, Gohring W, Mann K, Timpl R (2001) Mapping of binding sites for nidogens, fibulin-2, fibronectin and heparin to different IG modules of perlecan. J Mol Biol 311:529-541[Medline]

Iozzo RV (2001) Heparan sulphate proteoglycans: intricate molecules with intriguing functions. J Clin Invest 108:165-167[Free Full Text]

Iozzo RV, Cohen IR, Grassel S, Murdoch AD (1994) The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem J 302:625-639[Medline]

Iozzo RV, San Antonio JD (2001) Heparan sulphate proteoglycans: heavy hitters in the angiogenesis arena. J Clin Invest 108:349-355[Free Full Text]

Iwasaki M, Le AX, Helms JA (1997) Expression of indian hedgehog, bone morphogenetic protein 6 and gli during skeletal morphogenesis. Mech Dev 69:197-202[Medline]

Kai K, Takagi K, Iyama K, Kitaoka M, Yoshioka H, Mizuta H, Usuku G (1992) Immunohistochemical localisation of basal lamina components in the developing rat epiphyseal cartilage canals. Clin Orthop Rel Res 279:292-298[Medline]

Klint P, Claesson–Welsh L (1999) Signal transduction by fibroblast growth factor receptors. Front Biosci 4:D165-177[Medline]

Knox S, Melrose J, Whitelock J (2001) Electrophoretic, biosensor and bioactivity analyses of perlecans of different cellular origins. Proteomics 1:1534-1541[Medline]

Knox S, Merry C, Stringer S, Melrose J, Whitelock J (2002) Not all perlecans are created equal: interactions with fibroblast growth factor-2 (FGF-2) and FGF receptors. J Biol Chem 277:14657-14665[Abstract/Free Full Text]

Knudson CB, Knudson W (2001) Cartilage proteoglycans. Semin Cell Dev Biol 12:69-78[Medline]

Kunjathoor VV, Chiu DS, O'Brien KD, LeBouef RC (2002) Accumulation of biglycan and perlecan, but not versican, in lesions of murine models of atherosclerosis. Atheroscler Thromb Vasc Biol 22:462-468[Abstract/Free Full Text]

Mayne R, Zettergren JG, Mayne PM, Bedwell NW (1980) Isolation and partial characterization of basement membrane-like collagens from bovine thoracic aorta. Artery 7:262-280[Medline]

McArthur ME, Irving–Rodgers HFI, Byers S, Rodgers RJ (2000) Identification and immunolocalisation of decorin, versican, perlecan, nidogen, and chondroitin sulfate proteoglycans in bovine small-antral ovarian follicles. Biol Reprod 63:913-924[Abstract/Free Full Text]

McPherron AC, Lawler AM, Lee SJ (1999) Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. Nature Gene 22:260-264

Melrose J, Smith S, Knox S, Whitelock J (2002) Perlecan, the multi-domain proteoglycan of basement membrane is also a prominent pericellular component of hypertrophic chondrocytes of ovine vertebral growth plate and cartilaginous end plate cartilage. Histochem Cell Biol 118:269-280[Medline]

Mongiat M, Taylor K, Otto J, Aho S, Uitto J, Whitelock JM, Iozzo RV (2000) The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7. J Biol Chem 275:7095-7100[Abstract/Free Full Text]

Monsoro–Burq AH, Duprez D, Watanabe Y, Bontoux M, Vincent C, Brickell P, Le Douarin N (1996) The role of bone morphogenetic proteins in vertebral development. Development 122:3607-3616[Abstract/Free Full Text]

Murdoch AD, Dodge GR, Cohen I, Tuan RS, Iozzo RV (1992) Primary structure of the human heparan sulphate proteoglycan from basement membrane (HSPG-2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecule, and epidermal growth factor. J Biol Chem 267:8544-8557[Abstract/Free Full Text]

Murdoch AD, Liu B, Schwarting R, Tuan RS, Iozzo RV (1994) Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J Histochem Cytochem 42:239-249[Abstract/Free Full Text]

Nakahama M, Murakami T, Kusachi S, Naito I, Takeda K, Ohnishi H, Komatsubara I et al. (2000) Expression of perlecan proteoglycan in the infarct zone of mouse myocardial infarction. J Mol Cardiol 32:1087-1100[Medline]

Nakamura T, Aikawa T, Iwamoto–Enomoto M, Iwamoto M, Higuchi Y, Pacifici M, Kinto N et al. (1997) Induction of osteogenic differentiation by hedgehog proteins. Biochem Biophys Res Commun 237:465-469[Medline]

Nicole S, Davoine CS, Topaloglu H, Cattolico L, Barral D, Beighton P, Hamida CB et al. (2000) Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nature Gene 26:480-483

Noonan DM, Fulle A, Nalente P, Cai S, Horigan E, Sasaki M, Yamada Y et al. (1991) The complete sequence of perlecan, a basement membrane heparan sulphate proteoglycan, reveals extensive similarity with laminin-A chain, low density lipoprotein receptor and the neural cell adhesion molecule. J Biol Chem 266:22939-22947[Abstract/Free Full Text]

Nugent MA, Nugent HM, Iozzo RV, Sanchak K, Edelman ER (2000) Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia. Proc Natl Acad Sci USA 97:6722-6727[Abstract/Free Full Text]

Odermatt BF, Lang AB, Rüttner JR, Wintherhalten KH, Treb B (1984) Monoclonal antibodies to type IV collagen: useful reagents to demonstrate the heterotrimeric nature of the molecule. Proc Natl Acad Sci USA 81:7343-7347[Abstract]

Paine–Saunders S, Viviano BL, Economides AN, Saunders S (2002) Heparan sulphate proteoglycans retain noggin at the cell surface. A potential mechanism for shaping bone morphogenetic protein gradients. J Biol Chem 277:2089-2096[Abstract/Free Full Text]

Parums DV, Cordell JL, Micklem K, Heryet AR, Gatter KC, Mason DY (1990) JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol 43:752-757[Abstract]

Peters H, Wilm B, Sakai N, Imai K, Maas R, Balling R (1999) Pax-1 and Pax-9 synergistically regulate vertebral column development. Development 126:5399-5408[Abstract/Free Full Text]

Ratcliffe JF (1982) An evaluation of the intra-osseous arterial anastomoses in the human vertebral body at different ages. A microarteriographic study. J Anat 134:373-382[Medline]

Rayan GM, Haaksma CJ, Tomasek JL (2000) Basement membrane chondroitin sulfate proteoglycan and vascularisation of the developing mammalian limb bud. J Hand Surg 25A:150-158

Rudert M, Tillmann B (1993) Detection of lymph and blood vessels in the human intervertebral disc by histochemical and immunochemical methods. Anat Anz 175:237-242[Medline]

Skawina A, Litwin JA, Gorczyca J, Miodonski AJ (1997) The architecture of internal blood vessels in human fetal vertebral bodies. J Anat 191:259-267[Medline]

Smith CA, Tuan RS (1994) Human PAX gene expression and development of the vertebral column. Clin Orthop Rel Res 302:241-250[Medline]

Smith SE, French MM, Julian J, Paria BC, Dey SK, Carson DD (1997) Expression of heparan sulphate proteoglycan (perlecan) in the mouse blastocyst is regulated during normal and delayed implantation. Dev Biol 184:38-47[Medline]

SundarRaj N, Fite D, Ledbetter S, Chakravarti S, Hassell JR (1995) Perlecan is a component of cartilage matrix and promotes chondrocyte attachment. J Cell Sci 108:2663-2672[Abstract/Free Full Text]

Tapanadechopone P, Hassell JR, Rigatti B, Couchman JR (1999) Localisation of glycosaminoglycan substitution sites on domain V of mouse perlecan. Biochem Biophys Res Commun 265:680-690[Medline]

Tsumaki N, Tanaka K, Arikawa–Hirasawa E, Nakase T, Kimura T, Thomas JT, Ochi T et al. (1999) Role of CDMP-1 in skeletal morphogenesis: promotion of mesenchymal cell recruitment and chondrocyte differentiation. J Cell Biol 144:161-173[Abstract/Free Full Text]

Tu H, Sasaki T, Snellman A, Göhring W, Pirilä P, Timpl R, Pihlajaniemi T (2002) The type XIII collagen ectodomain is a 150nm rod and capable of binding to fibronectin, nidogen-2, perlecan, and heparin. J Biol Chem 277:23092-23099[Abstract/Free Full Text]

von Kossa J (1901) Uber die in organismus Kunstlich erzeugbaren Verkalkungen. Beitr Pathol Anat Allg Pathol 29:163-202

Wang L, Verbruggen G, Almqvist KF, Elewaut D, Broddelez C, Veys EM (2001) Flow-cytometric analysis of the human articular chondrocyte phenotype. Osteoarthritis Cartilage 9:73-84[Medline]

Whalen JL, Parke WW, Mazur JM, Stauffer ES (1985) The intrinsic vasculature of developing vertebral end plates and its nutritive significance to the intervertebral discs. J Pediatr Orthop 5:403-410[Medline]

Whitelock JM, Graham LD, Melrose J, Murdoch AD, Iozzo RV, Underwood A (1999) Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells. Matrix Biol 18:163-178[Medline]

Whitelock JM, Murdoch AD, Iozzo RV, Underwood PA (1996) The degradation of human endothelial cell-derived perlecan and release of bound fibroblast growth factor by stromelysin, collagenase, plasmin and heparanase. J Biol Chem 271:10079-10086[Abstract/Free Full Text]

Yamaguchi A, Komori T, Suda T (2000) Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocrine Rev 21:393-411[Abstract/Free Full Text]

Yan H-C, Newman PJ, Albelda SM (1995) In Schlossmann JM, ed. Leucocyte Typing V. White Cell Differentiation Antigen. Oxford, New York, Tokyo, Oxford University Press, 12161–12163

Yuasa T, Kataoka H, Kinto N, Iwamoto M, Enomoto–Iwamoto M, Iemura S, Ueno N et al. (2002) Sonic hedgehog is involved in osteoblast differentiation by cooperating with BMP-2. J Cell Physiol 193:225-232[Medline]

Zhu Y, McAlinden A, Sandell L (2001) Type IIA procollagen in development of the human intervertebral disc: regulated expression of the NH2-propeptide by enzymic processing reveals a unique developmental pathway. Dev Dyn 220:350-362[Medline]